We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UTSI:NASDAQUTStarcom Holdings Corp Analysis

Data as of 2026-05-08 - not real-time

$2.50

Latest Price

8/10Risk

Risk Level: High

Executive Summary

UTStarcom is trading just above its identified support level, with the 20‑day SMA marginally above the 50‑day SMA, suggesting a fragile neutral trend.
Technical signals are weak: the MACD histogram is negative, the signal line is bearish, and volume has been on a decreasing trajectory, all pointing to short‑term downside pressure. The stock exhibits exceptionally high 30‑day volatility yet a near‑zero beta, indicating that price swings are driven more by company‑specific factors than market movements. On the fundamentals side, the company carries a strong cash buffer relative to its modest debt, but it is plagued by negative revenue growth, deep operating losses, and negative margins, which undermine earnings‑based valuations. The price‑to‑book ratio is well below one, hinting at potential undervaluation relative to assets, but the lack of profitability, high volatility, and exposure to Chinese telecom regulatory environment elevate risk. Consequently, while the balance sheet offers some cushion, the combination of deteriorating earnings, weak technical momentum, and sector‑specific headwinds suggests caution for investors.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • bearish MACD histogram
  • decreasing trading volume
  • price hovering near support with high volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • persistent negative earnings and margins
  • strong cash position offset by operating losses
  • uncertain regulatory environment in China

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • price-to-book ratio below one indicating asset undervaluation
  • low debt and ample cash reserves
  • potential turnaround if revenue growth stabilizes

Key Metrics & Analysis

Financial Health

Revenue Growth-15.80%
Profit Margin-88.55%
P/E Ratio-15.6
ROE-19.45%
ROA-8.62%
Debt/Equity3.10
P/B Ratio0.6
Op. Cash Flow$-8821000
Free Cash Flow$-5560125
Industry P/E37.2

Technical Analysis

TrendNeutral
RSI52.6
Support$2.25
Resistance$2.70
MA 20$2.47
MA 50$2.43
MA 200$2.44
MACDBearish
VolumeDecreasing
Fear & Greed Index90.93

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.12
Volatility56.15%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.